Back to GILD

GILEAD SCIENCES, INC. Free Cash Flow 2013-2026 | GILD

Beta

What is GILEAD SCIENCES, INC.'s current free cash flow?

GILEAD SCIENCES, INC. (GILD) annual free cash flow for 2025 was $9.46B, a 8.24% decline from 2024. GILEAD SCIENCES, INC. free cash flow for the quarter ending March 31, 2026 was $2.43B.

What was GILEAD SCIENCES, INC.'s free cash flow in 2024?

GILEAD SCIENCES, INC. annual free cash flow for 2024 was $10.30B, a 38.86% increase from 2023.

What was GILEAD SCIENCES, INC.'s free cash flow in 2023?

GILEAD SCIENCES, INC. annual free cash flow for 2023 was $7.42B, a 11.06% decline from 2022.

What is GILEAD SCIENCES, INC.'s 5-year free cash flow CAGR?

GILEAD SCIENCES, INC. free cash flow grew at a compound annual growth rate (CAGR) of 4.69% from FY2020 to FY2025, going from $7.52B to $9.46B over 5 years.

Free Cash Flow History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+4.7%
FY2020
$7.52B
→
FY2025
$9.46B
131819202122232425
5 years selected
Free Cash Flow History
PeriodValueChangeSource
FY2025$9.46B-8.2%10-K
FY2024$10.30B+38.9%10-K
FY2023$7.42B-11.1%10-K
FY2022$8.34B-22.8%10-K
FY2021$10.80B+43.7%10-K
FY2020$7.52B-9.6%10-K
FY2019$8.32B+11.3%10-K
FY2018$7.48B+151.6%10-K
FY2013$2.97B-10-K
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →